Anticorps Recombinant de lapin anti-IL-17A
IL-17A Recombinant Antibody for FC
Hôte / Isotype
Lapin / IgG
Réactivité testée
rat
Applications
FC
Conjugaison
Non conjugué
CloneNo.
250413G7
N° de cat : 98564-1-PBS
Synonymes
Galerie de données de validation
Informations sur le produit
98564-1-PBS cible IL-17A dans les applications de FC et montre une réactivité avec des échantillons rat
| Réactivité | rat |
| Hôte / Isotype | Lapin / IgG |
| Clonalité | Recombinant |
| Type | Anticorps |
| Immunogène | IL-17A Protéine recombinante Eg3339 |
| Nom complet | similar to Interleukin-17 precursor (IL-17) (Cytotoxic T lymphocyte-associated antigen 8) (CTLA-8) |
| Masse moléculaire calculée | 17kDa |
| Symbole du gène | LOC301289 |
| Identification du gène (NCBI) | 301289 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Purification par protéine A |
| Tampon de stockage | PBS only |
| Conditions de stockage | Store at -80°C. |
Informations générales
IL-17A, also named as IL-17, is a proinflammatory cytokine. IL-17, synthesized only by memory T cells and natural killer cells, has pleiotropic effects, mainly in the recruitment and activation of neutrophils. This cytokine regulates the activities of NF-kappaB and mitogen-activated protein kinases. This cytokine can stimulate the expression of IL6 and cyclooxygenase-2 (PTGS2/COX-2), as well as enhance the production of nitric oxide (NO). High levels of this cytokine are associated with several chronic inflammatory diseases including rheumatoid arthritis, psoriasis and multiple sclerosis. The IL-17 receptor is a type I transmembrane protein, that is widely expressed on epithelial cells, fibroblasts, B and T cells, and monocytic cells. In psoriatic skin lesions, both Th17 cells and their downstream effector molecules, e.g. IL-17 and IL-22, are highly increased.



